Clinical Trials Directory

Trials / Sponsors / Hangzhou Highlightll Pharmaceutical Co., Ltd

Hangzhou Highlightll Pharmaceutical Co., Ltd

Industry · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 32025-03-10
RecruitingA Study of Efficacy and Safety of TLL-018 in CSU Participants
Chronic Spontaneous Urticaria
Phase 32024-12-24
UnknownA Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDM
Rheumatoid Arthritis
Phase 32023-11-15
CompletedEvaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese
Atopic Dermatitis
Phase 12023-07-12
CompletedThe Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
Plaque Psoriasis
Phase 22023-01-19
CompletedSafety and Efficacy of TLL018 in Patients With Plaque Psoriasis
Moderate to Severe Plaque Psoriasis
Phase 12022-06-10
CompletedSafety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
Chronic Spontaneous Urticaria
Phase 12022-05-10
CompletedThe Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 22022-02-16